Cognitive and affective disorders associated to HIV infection in the HAART era: Findings from the NeuroICONA study

F. Starace, L. Bartoli, M. S. Aloisi, A. Antinori, P. Narciso, G. Ippolito, L. Ravasio, M. C. Moioli, D. Vangi, L. Gennero, O. V. Coronado, A. Giacometti, S. Nappa, M. L. Perulli, V. Montesarchio, A. La Gala, F. Ricci, L. Cristiano, M. De Marco, C. IzzoP. Pezzotti, A. D'Arminio Monforte

Research output: Contribution to journalArticlepeer-review


Objective: To assess the natural story of HIV-associated affective and cognitive disorders and the relationship with clinical, pharmacological, immunological and behavioural factors. Method: A total of 395 HIV-positive patients, naive to Highly Active Antirectroviral therapy (HAART), with no severe psychiatric disorders have been enrolled in the Neuro-ICONA Study. All participants were administered a comprehensive data collection instrument including an addiction behaviour survey, a medical problem list, a psychiatric assessment, a validated neuropsychological test battery. Results: The global prevalence of cognitive impairment and of prominent depressive symptomatology were 17.9 and 15.5%, respectively. A significant difference in the prevalence of prominent depressive symptomatology was observed between patients in HAART and those not taking HAART(14.1 vs. 23.8%; P = 0.05). Conclusion: Depressive and cognitive disorders affect a substantial proportion of HIV-seropositive subjects. The prevalence of prominent depressive symptomatology appears to significantly vary in relationship to the therapeutic protocol.

Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalActa Psychiatrica Scandinavica
Issue number1
Publication statusPublished - 2002


  • Cognitive disorder
  • Depression
  • HIV infections
  • Neuropsychological test

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)


Dive into the research topics of 'Cognitive and affective disorders associated to HIV infection in the HAART era: Findings from the NeuroICONA study'. Together they form a unique fingerprint.

Cite this